Search
SOLACI Congress
HomeCONGRESSInternational Congresses

International Congresses

View Category
Day 3

POST -IT: The FFR modifies strategy in almost half of patients

The use of FFR to guide treatment showed improved outcomes in previous studies. However, there are few...
solaci -
Learn More
Day 3

REDUCE-HTN: safety and efficacy of new bipolar device for renal denervation

This study included 146 patients with resistant hypertension who were medicated with an average of 5.4 drugs....
solaci -
Learn More
Day 2

IBERIAN: appendage occlusion registry

The aim of this study was to observe the rate of thromboembolic and hemorrhagic events in a...
solaci -
Learn More
Day 3

ADVANCE II: Low incidence of permanent pacemaker for self -expandable valve

The incidence of permanent pacemaker implantation (PPM) is variable between the different series within 30 days of...
solaci -
Learn More
Day 3

SIMPLICITY HTN -3: subgroup analysis identifies potential confounders

Initial studies showed a blood pressure significant reduction to 3 years in patients with resistant hypertension, while...
solaci -
Learn More
Day 3

TITAN-AMI: Final results of bio-active coated stent

Previous studies suggest the excellent performance of the bioactive coated stent TITAN 2 compared with drug-eluting stents...
solaci -
Learn More
Day 3

Safety and efficacy of a new multi-electrode device for simultaneous renal ablation

This study aimed to establish the safety and effectiveness of renal denervation using the new multielectrode device...
solaci -
Learn More
Day 2

COMPARE II: biolimus eluting stent with biodegradable polymer versus everolimus at 3 years.

This study randomized 2:1 - 2707 patients to biolimus eluting stent with biodegradable polymer versus everolimus eluting...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy